About
About PolyNovo Limited
PolyNovo Limited designs, manufactures, and sells biodegradable medical devices in Australia, New Zealand, the United States, the United Kingdom, Ireland, Singapore, India, Hong Kong, and China. The company offers NovoSorb Biodegradable Temporising Matrix, a dermal matrix for the regeneration of the dermis when lost through extensive surgery, trauma, or burn; NovoSorb MTX for burns, chronic, trauma, and surgical wounds; and hernia repair, plastics and reconstructive device products. The company was formerly known as Calzada Limited and changed its name to PolyNovo Limited in November 2014. PolyNovo Limited was incorporated in 1998 and is headquartered in Port Melbourne, Australia.
Visit company website
5 years, 5 months ago
PolyNovo Limited is currently in a long term downtrend where the price is trading 15.2% below its 200 day moving average.
From a valuation standpoint, the stock is 70.1% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 76.9.
PolyNovo Limited's total revenue rose by 25.3% to $13M since the same quarter in the previous year.
Its net income has dropped by 46.3% to $-4M since the same quarter in the previous year.
Finally, its free cash flow grew by 58.9% to $-2M since the same quarter in the previous year.
Based on the above factors, PolyNovo Limited gets an overall score of 3/5.